IOVA
IOVANCE BIOTHERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$8.48
−11.30%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+110.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 2, 2026 | Berkowitz Noah · officer: Chief Medical Officer | A-Award | 135,000 | $15 |
| Oct 2, 2026 | Berkowitz Noah · officer: Chief Medical Officer | A-Award | 180,000 | $0.00 |
| Sep 10, 2026 | BILINSKY IGOR · officer: Chief Operating Officer | F-InKind | 3,976 | $8.70 |
| Sep 10, 2026 | Puri Raj K. · officer: Chief Regulatory Officer | M-Exempt | 9,766 | $0.00 |
| Sep 10, 2026 | Vogt Frederick G · director, officer: Interim CEO & General Counsel | F-InKind | 6,638 | $8.70 |
| Sep 10, 2026 | Puri Raj K. · officer: Chief Regulatory Officer | F-InKind | 4,478 | $8.70 |
| Sep 10, 2026 | Vogt Frederick G · director, officer: Interim CEO & General Counsel | M-Exempt | 15,626 | $0.00 |
| Sep 10, 2026 | BILINSKY IGOR · officer: Chief Operating Officer | M-Exempt | 7,813 | $0.00 |
| Sep 3, 2026 | Puri Raj K. · officer: Chief Regulatory Officer | F-InKind | 2,508 | $8.28 |
| Sep 3, 2026 | BILINSKY IGOR · officer: Chief Operating Officer | F-InKind | 4,472 | $8.28 |
| Sep 3, 2026 | Vogt Frederick G · director, officer: Interim CEO & General Counsel | M-Exempt | 41,669 | $0.00 |
| Sep 3, 2026 | Puri Raj K. · officer: Chief Regulatory Officer | M-Exempt | 5,470 | $0.00 |
| Sep 3, 2026 | BILINSKY IGOR · officer: Chief Operating Officer | M-Exempt | 8,789 | $0.00 |
| Sep 3, 2026 | Vogt Frederick G · director, officer: Interim CEO & General Counsel | F-InKind | 17,702 | $8.28 |
| Aug 12, 2026 | Kirby Daniel Gordon · officer: Chief Commercial Officer | F-InKind | 2,436 | $6.40 |
| Aug 12, 2026 | Kirby Daniel Gordon · officer: Chief Commercial Officer | M-Exempt | 10,001 | $0.00 |
| Aug 10, 2026 | Roche Corleen M. · officer: Chief Financial Officer | F-InKind | 21,238 | $6.21 |
| Aug 10, 2026 | Roche Corleen M. · officer: Chief Financial Officer | M-Exempt | 49,995 | $0.00 |
| Jun 18, 2026 | WEISER MICHAEL · director | A-Award | 90,316 | $0.00 |
| Jun 18, 2026 | Maynard Ryan D · director | A-Award | 90,316 | $0.00 |
| Jun 18, 2026 | Puri Raj K. · officer: Chief Regulatory Officer | A-Award | 15,000 | $0.00 |
| Jun 18, 2026 | Dukes Iain D. · director | A-Award | 180,632 | $0.00 |
| Jun 18, 2026 | Countouriotis Athena · director | A-Award | 90,316 | $0.00 |
| Jun 9, 2026 | Puri Raj K. · officer: Chief Regulatory Officer | F-InKind | 3,843 | $4.23 |
| Jun 9, 2026 | GRAF FINCKENSTEIN FRIEDRICH · officer: Chief Medical Officer | F-InKind | 3,976 | $4.23 |
| Jun 9, 2026 | BILINSKY IGOR · officer: Chief Operating Officer | M-Exempt | 7,813 | $0.00 |
| Jun 9, 2026 | Vogt Frederick G · director, officer: Interim CEO & General Counsel | F-InKind | 6,638 | $4.23 |
| Jun 9, 2026 | Vogt Frederick G · director, officer: Interim CEO & General Counsel | M-Exempt | 15,625 | $0.00 |
| Jun 9, 2026 | BILINSKY IGOR · officer: Chief Operating Officer | F-InKind | 3,976 | $4.23 |
| Jun 9, 2026 | GRAF FINCKENSTEIN FRIEDRICH · officer: Chief Medical Officer | M-Exempt | 7,813 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 107Increased 238Reduced 119Sold out 71
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 36,957,681 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 31,080,505 | May 13, 2026 |
| MHR FUND MANAGEMENT LLC | Unchanged | 28,967,103 | May 15, 2026 |
| MHR FUND MANAGEMENT LLC | Unchanged | 28,967,103 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 24,478,268 | Sep 22, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 19,010,697 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 18,204,248 | Aug 13, 2026 |
| STATE STREET CORP | Reduced | 17,448,108 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 16,617,737 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 14,388,999 | Aug 13, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 13,687,433 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 11,700,844 | May 8, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 10,324,826 | Aug 12, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 9,414,292 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 8,760,060 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 2, 2026